Sage Therapeutics Inc (SAGE)
11.46
-0.54
(-4.50%)
USD |
NASDAQ |
Jun 17, 13:33
Sage Therapeutics Market Cap: 689.69M for June 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 14, 2024 | 722.18M |
| June 13, 2024 | 692.09M |
| June 12, 2024 | 652.97M |
| June 11, 2024 | 637.93M |
| June 10, 2024 | 655.98M |
| June 07, 2024 | 636.73M |
| June 06, 2024 | 648.16M |
| June 05, 2024 | 660.20M |
| June 04, 2024 | 642.74M |
| June 03, 2024 | 668.62M |
| May 31, 2024 | 668.62M |
| May 30, 2024 | 692.09M |
| May 29, 2024 | 653.58M |
| May 28, 2024 | 717.97M |
| May 24, 2024 | 708.94M |
| May 23, 2024 | 681.26M |
| May 22, 2024 | 728.20M |
| May 21, 2024 | 725.19M |
| May 20, 2024 | 672.83M |
| May 17, 2024 | 704.13M |
| May 16, 2024 | 722.79M |
| May 15, 2024 | 704.73M |
| May 14, 2024 | 721.58M |
| May 13, 2024 | 732.11M |
| May 10, 2024 | 716.17M |
| Date | Value |
|---|---|
| May 09, 2024 | 742.65M |
| May 08, 2024 | 745.66M |
| May 07, 2024 | 781.16M |
| May 06, 2024 | 797.41M |
| May 03, 2024 | 838.94M |
| May 02, 2024 | 788.69M |
| May 01, 2024 | 799.22M |
| April 30, 2024 | 838.94M |
| April 29, 2024 | 853.38M |
| April 26, 2024 | 823.89M |
| April 25, 2024 | 817.27M |
| April 24, 2024 | 842.55M |
| April 23, 2024 | 779.36M |
| April 22, 2024 | 775.75M |
| April 19, 2024 | 802.23M |
| April 18, 2024 | 784.47M |
| April 17, 2024 | 756.49M |
| April 16, 2024 | 940.64M |
| April 15, 2024 | 921.99M |
| April 12, 2024 | 929.21M |
| April 11, 2024 | 997.22M |
| April 10, 2024 | 989.99M |
| April 09, 2024 | 994.21M |
| April 08, 2024 | 999.02M |
| April 05, 2024 | 988.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
636.73M
Minimum
Jun 07 2024
9.777B
Maximum
Jul 12 2019
3.063B
Average
2.507B
Median
Market Cap Benchmarks
| Biogen Inc | 33.14B |
| Vanda Pharmaceuticals Inc | 383.53M |
| Ligand Pharmaceuticals Inc | 1.416B |
| ADMA Biologics Inc | 2.418B |
| Axsome Therapeutics Inc | 3.580B |
Market Cap Related Metrics
| PS Ratio | 7.545 |
| Price to Book Value | 0.9772 |
| Price | 11.46 |
| Earnings Yield | -73.21% |